Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis
Ippazio Cosimo Antonazzo, Carla Fornari, Sandy Maumus-Robert, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 2, pp. 178-178
Open Access | Times Cited: 10

Showing 10 citing articles:

Increased antidepressant use during the COVID-19 pandemic: Findings from the Friuli Venezia Giulia region, Italy, 2015–2020
Laura Pazzagli, Johan Reutfors, Ejlli Lucian, et al.
Psychiatry Research (2022) Vol. 315, pp. 114704-114704
Open Access | Times Cited: 31
Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care
Pietro Ferrara, Giulia Dallagiacoma, Federica Alberti, et al.
Preventive Medicine (2022) Vol. 164, pp. 107264-107264
Open Access | Times Cited: 29
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic
Mikael Tiger, Giulio Castelpietra, Rikke Wesselhöeft, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Effect of the COVID-19 pandemic on the psychotropic drug consumption
Paul Benistand, Philippe Vorilhon, Catherine Laporte, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 17
The Impact of COVID-19 on Mental Healthcare Utilization in Switzerland Was Strongest Among Young Females—Retrospective Study in 2018–2020
Yael Rachamin, Levy Jäger, Reka Schweighoffer, et al.
International Journal of Public Health (2023) Vol. 68
Open Access | Times Cited: 5
Trends in incident diagnoses and drug prescriptions for anxiety and depression during the COVID-19 pandemic: an 18-month follow-up study based on the UK Biobank
Yue Wang, Fenfen Ge, Junren Wang, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Advanced oxidation processes for degradation of pharmaceuticals used during COVID-19 pandemic
Irwing M. Ramírez-Sánchez, Ezrah Mariam, Ajay Kumar, et al.
Elsevier eBooks (2024), pp. 337-362
Closed Access | Times Cited: 1
Benzodiazepines and Z-hypnotics consumption in long-COVID-19 patients: Gender differences and associated factors
Pilar Carrasco‐Garrido, César Fernández‐de‐las‐Peñas, Valentín Hernández‐Barrera, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Impact of the COVID-19 Pandemic on the Use of Antidepressants by Young Adults in the ASL TO4 Regione Piemonte (Italy)
Lucrezia Greta Armando, Raffaella Baroetto Parisi, Cristina Rolando, et al.
Pharmacy (2024) Vol. 12, Iss. 1, pp. 21-21
Open Access
Effects of a multilayered crisis on psychiatric hospitalizations in a university hospital in Lebanon; a retrospective study
Anthony Kassab, Charline El Hachem, Georges Raad, et al.
Psychiatry Research (2022) Vol. 318, pp. 114940-114940
Closed Access | Times Cited: 2
Page 1

Scroll to top